Anemia and Erythrocyte Disorders: Mechanisms, Types, and Clinical Features

Anemia and Erythrocyte Disorders

Overview of Oxygen Transport and Erythropoiesis

Anemia and related erythrocyte disorders are conditions that affect the oxygen-carrying capacity of blood, primarily through changes in red blood cell (RBC) number, structure, or function. The regulation of erythrocyte production (erythropoiesis) is tightly controlled by feedback mechanisms involving the kidneys and bone marrow.

• Oxygen Transport: Nearly all (97%) of oxygen in blood is transported bound to hemoglobin in RBCs; only 3% is dissolved in plasma.

• Erythropoiesis: The process by which new RBCs are produced in the bone marrow, stimulated by erythropoietin (EPO) released from the kidneys in response to hypoxia (low oxygen levels).

• Feedback Regulation: Anemia or hypoxia triggers increased EPO production, stimulating the bone marrow to produce more RBCs.

Key Points in Oxygen Transport and Anemia

• Hemoglobin saturation and oxygen delivery depend on partial pressure of oxygen (PO2), pH, and temperature.

• CO2 is transported in blood as bicarbonate, dissolved gas, or bound to hemoglobin.

• Anemia leads to decreased oxygen-carrying capacity, resulting in tissue hypoxia and compensatory mechanisms such as increased heart rate and respiratory rate.

Classification of Anemia and Polycythemia

Types of Anemia

Anemia is classified based on the underlying cause, which may include decreased RBC production, increased RBC destruction, or blood loss. Polycythemia refers to increased RBC mass.

Anemia Type	Subtypes/Examples
Decreased RBC Production	Aplastic anemia, chronic renal failure, iron deficiency, vitamin B12/folate deficiency, thalassemia
Increased RBC Destruction	Sickle cell anemia, hereditary spherocytosis, G6PD deficiency, hemolytic disease of the newborn
Blood Loss	Acute or chronic hemorrhage
Polycythemia	Relative (dehydration), absolute (primary/secondary polycythemia)

General Effects and Clinical Manifestations of Anemia

• Symptoms: Fatigue, pallor, shortness of breath, tachycardia, and dizziness due to reduced oxygen delivery.

• Compensatory Mechanisms: Increased cardiac output, redistribution of blood flow, and increased 2,3-DPG in RBCs to enhance oxygen release.

• Severity: Symptoms depend on the rate of onset, degree of anemia, and underlying cause.

Anemia Related to Decreased RBC Production

Aplastic Anemia

Aplastic anemia is characterized by failure of the bone marrow to produce adequate numbers of all blood cells, leading to pancytopenia (deficiency of RBCs, WBCs, and platelets).

• Etiology: Can be caused by radiation, chemicals, drugs, infections, or idiopathic factors.

• Laboratory Findings: Low RBC, WBC, and platelet counts; low reticulocyte count.

• Treatment: Immunosuppressive therapy, bone marrow transplantation.

Anemia of Chronic Kidney Disease

Chronic kidney disease leads to decreased erythropoietin production, resulting in reduced RBC synthesis.

• Laboratory Findings: Normocytic, normochromic anemia; low reticulocyte count.

• Treatment: Erythropoiesis-stimulating agents, iron supplementation.

Anemia Due to Vitamin B12 or Folate Deficiency

Deficiency of vitamin B12 or folate impairs DNA synthesis, leading to megaloblastic anemia with large, immature RBCs.

• Etiology: Poor dietary intake, malabsorption, increased requirements.

• Laboratory Findings: Macrocytic anemia (high MCV), low reticulocyte count, hypersegmented neutrophils.

• Treatment: Vitamin B12 or folate supplementation.

Iron Deficiency Anemia

Iron deficiency is the most common cause of anemia worldwide, resulting in microcytic, hypochromic RBCs.

• Etiology: Chronic blood loss, poor dietary intake, increased requirements.

• Laboratory Findings: Low MCV, low MCHC, low serum ferritin, high total iron-binding capacity (TIBC).

• Treatment: Iron supplementation and treatment of underlying cause.

Anemia Related to Inherited Disorders of the Red Cell

Thalassemia

Thalassemias are inherited disorders characterized by decreased synthesis of either alpha or beta globin chains, leading to ineffective erythropoiesis and hemolysis.

• Types: Alpha-thalassemia, beta-thalassemia.

• Laboratory Findings: Microcytic, hypochromic anemia; target cells on blood smear.

• Treatment: Regular transfusions, iron chelation therapy, bone marrow transplantation.

Sickle Cell Anemia

Sickle cell anemia is caused by a mutation in the beta-globin gene, resulting in abnormal hemoglobin S that polymerizes under low oxygen conditions, causing RBCs to become rigid and sickle-shaped.

• Pathophysiology: Sickled RBCs occlude small vessels, leading to ischemia, pain, and organ damage; increased hemolysis causes anemia and jaundice.

• Laboratory Findings: Sickle-shaped RBCs, increased reticulocyte count, target cells.

• Treatment: Hydroxyurea, transfusions, bone marrow transplantation.

Laboratory Findings for Erythrocyte Disorders

Laboratory evaluation of anemia includes complete blood count (CBC), reticulocyte count, blood smear, and specific tests for hemolysis or nutrient deficiencies.

Disease	HCT	HB	MCV	MCH	MCHC	Retic	RBC	WBC	PLT	Blood Smear	Laboratory Tests
Relative anemia	Low	Low	Normal	Normal	Normal	Low	Low	Normal	Normal	Normal	Decreased plasma volume
Aplastic anemia	Low	Low	Normal	Normal	Normal	Low	Low	Low	Low	Normocytic, normochromic	Bone marrow biopsy
Iron deficiency	Low	Low	Low	Low	Low	Low	Low	Normal	Normal	Microcytic, hypochromic	Serum ferritin, TIBC
Sickle cell anemia	Low	Low	Normal	Normal	Normal	High	Low	Normal	Normal	Sickled cells	Hemoglobin electrophoresis
Hereditary spherocytosis	Low	Low	Normal	Normal	Normal	High	Low	Normal	Normal	Spherocytes	Osmotic fragility test
G6PD deficiency	Low	Low	Normal	Normal	Normal	High	Low	Normal	Normal	Bite cells, Heinz bodies	G6PD assay

Inherited and Acquired Hemolytic Anemias

Hereditary Spherocytosis

Hereditary spherocytosis is caused by defects in RBC membrane proteins, leading to spherical, fragile RBCs that are prone to hemolysis.

• Laboratory Findings: Spherocytes on blood smear, increased osmotic fragility.

• Treatment: Splenectomy in severe cases.

Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

G6PD deficiency is an X-linked disorder causing episodic hemolysis in response to oxidative stress (e.g., certain drugs, infections, fava beans).

• Laboratory Findings: Bite cells, Heinz bodies on blood smear.

• Treatment: Avoidance of triggers.

Hemolytic Disease of the Newborn (HDN)

HDN results from maternal antibodies against fetal RBC antigens, leading to hemolysis in the fetus or newborn.

• Prevention: Administration of anti-Rh immunoglobulin to Rh-negative mothers.

Summary Table: Complications of Sickle Cell Anemia

Complication	Incidence	Features
Painful crisis	50% of patients with HbSS	Mild to severe pain, often recurrent
Chest syndrome	Variable	Acute chest pain, fever, pulmonary infiltrates
Priapism	Common in males	Painful, prolonged erection
Stroke	Children and adults	Neurological deficits
Leg ulcers	Adolescents and adults	Chronic, non-healing ulcers

Key Points

• Anemia results in tissue hypoxia and compensatory physiological responses.

• Classification of anemia is based on etiology, RBC indices, and laboratory findings.

• Inherited and acquired disorders can affect RBC production, structure, or survival.

• Laboratory evaluation is essential for diagnosis and management.